Vertex Pharmaceuticals Inc.

NMS : VRTX
Pharmaceuticals
Cambridge Massachusetts
2011 Revenue (US$ Millions)$1,411
2010 Revenue (US$ Millions)$143
Revenue Growth (%)883.91%
Net Income (US$ Millions)$30
Common Shares Outstanding (Millions)$209
Earnings Per Share (US$)$0.14
Earnings Per Share Growth (%)-88%
Price To Earnings Ratio414.36
Total Equity (US$ Millions)$787
Profit Growth (%)-88888
Profit Margin (%)2.10%
Return On Equity (%)5.87%
Long Term Debt (US$ Millions)$400
Debt To Equity Ratio (%)0.51%
Market Capitalization (US$ Millions)$6,951
Total Assets (US$ Millions)$2,204
Return on Assets (%)1.71
Current Assets (US$ Millions)$1,331
Inventories (US$ Millions)$112
Current Liabilities (US$ Millions)$392
Cost of Goods Sold (US$ Millions)$64
Asset Turnover0.64
Inventory TurnoverN/A